Pierre Chelle
Waterloo, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with FIX-Fc or N9-GP extended half-life FIX concentrates.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 26, 2026
Country-level prediction of blood type distribution in hemophilia A in support of factor VIII consumption.
Journal: Research and practice in thrombosis and haemostasis
Published: August 28, 2025
An Open-Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 29, 2025
A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 10, 2024
Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 24, 2024
Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models.
Journal: British journal of clinical pharmacology
Published: February 26, 2024
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS-Hemo platform.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 26, 2024
Canadian clinical experience on switching from standard half-life recombinant factor VIII (rFVIII), octocog alfa, to extended half-life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 15, 2023
Integrated Electrochemical Aptamer Biosensing and Colorimetric pH Monitoring via Hydrogel Microneedle Assays for Assessing Antibiotic Treatment.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 22, 2023
Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi-country severe WAPPS-Hemo haemophilia patients.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: August 18, 2023
A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 31, 2022
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 13, 2021
Last Updated: 09/26/2026